Compare NOV Inc. Common Stock (NOV) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NOV Inc. Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? NOV Inc. Common Stock trades at $19.08 (market cap $6.64B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: NOV Inc. Common Stock is the larger of the two by market cap, and NOV Inc. Common Stock pays a 1.93% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NOV Inc. Common Stock for 0 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| NOV | RLAY | |
|---|---|---|
Market Cap | $6.64B | $3.94B |
Volume | 4,238,905 | 3,432,928 |
Sector | Energy | Health |
52-Week High | $21.71 | $20.75 |
52-Week Low | $12.31 | $6.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $7.80B | $3.06B |
Dividend Yield | 1.93% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About NOV Inc. Common Stock
NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.
Read more on NOV →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
